Whole genome sequencing of Streptococcus pneumoniae: development, evaluation and verification of targets for serogroup and serotype prediction using an automated pipeline.
Streptococcus pneumoniae typically express one of 92 serologically distinct capsule polysaccharide (cps) types (serotypes). Some of these serotypes are closely related to each other; using the commercially available typing antisera, these are assigned to common serogroups containing types that show cross-reactivity. In this serotyping scheme, factor antisera are used to allocate serotypes within a serogroup, based on patterns of reactions. This serotyping method is technically demanding, requires considerable experience and the reading of the results can be subjective. This study describes the analysis of the S. pneumoniae capsular operon genetic sequence to determine serotype distinguishing features and the development, evaluation and verification of an automated whole genome sequence (WGS)-based serotyping bioinformatics tool, PneumoCaT (Pneumococcal Capsule Typing). Initially, WGS data from 871 S. pneumoniae isolates were mapped to reference cps locus sequences for the 92 serotypes. Thirty-two of 92 serotypes could be unambiguously identified based on sequence similarities within the cps operon. The remaining 60 were allocated to one of 20 'genogroups' that broadly correspond to the immunologically defined serogroups. By comparing the cps reference sequences for each genogroup, unique molecular differences were determined for serotypes within 18 of the 20 genogroups and verified using the set of 871 isolates. This information was used to design a decision-tree style algorithm within the PneumoCaT bioinformatics tool to predict to serotype level for 89/94 (92 + 2 molecular types/subtypes) from WGS data and to serogroup level for serogroups 24 and 32, which currently comprise 2.1% of UK referred, invasive isolates submitted to the National Reference Laboratory (NRL), Public Health England (June 2014-July 2015). PneumoCaT was evaluated with an internal validation set of 2065 UK isolates covering 72/92 serotypes, including 19 non-typeable isolates and an external validation set of 2964 isolates from Thailand (n = 2,531), USA (n = 181) and Iceland (n = 252). PneumoCaT was able to predict serotype in 99.1% of the typeable UK isolates and in 99.0% of the non-UK isolates. Concordance was evaluated in UK isolates where further investigation was possible; in 91.5% of the cases the predicted capsular type was concordant with the serologically derived serotype. Following retesting, concordance increased to 99.3% and in most resolved cases (97.8%; 135/138) discordance was shown to be caused by errors in original serotyping. Replicate testing demonstrated that PneumoCaT gave 100% reproducibility of the predicted serotype result. In summary, we have developed a WGS-based serotyping method that can predict capsular type to serotype level for 89/94 serotypes and to serogroup level for the remaining four. This approach could be integrated into routine typing workflows in reference laboratories, reducing the need for phenotypic immunological testing.
Respiratory and Vaccine Preventable Bacterial Reference Unit, Public Health England, London, United Kingdom.
Georgia
G
Kapatai
Respiratory and Vaccine Preventable Bacterial Reference Unit, Public Health England, London, United Kingdom.
Carmen L
CL
Sheppard
Infectious Disease Informatics, Public Health England, London, United Kingdom.
Ali
A
Al-Shahib
Respiratory and Vaccine Preventable Bacterial Reference Unit, Public Health England, London, United Kingdom.
David J
DJ
Litt
Infectious Disease Informatics, Public Health England, London, United Kingdom.
Anthony P
AP
Underwood
Respiratory and Vaccine Preventable Bacterial Reference Unit, Public Health England, London, United Kingdom.
Timothy G
TG
Harrison
Respiratory and Vaccine Preventable Bacterial Reference Unit, Public Health England, London, United Kingdom.
Norman K
NK
Fry
Bacterial; Bioinformatics; Genomics; Pneumococcus; Serotyping; WGS
J Biol Chem. 2011 Oct 14;286(41):35813-22
21859716
J Clin Microbiol. 2011 May;49(5):1784-9
21411589
J Clin Microbiol. 2014 Sep;52(9):3271-6
24958802
Lancet Infect Dis. 2015 May;15(5):535-43
25801458
J Exp Med. 1999 Jul 19;190(2):241-51
10432287
J Clin Microbiol. 2013 Oct;51(10):3395-9
23824778
Microbiology. 2003 Feb;149(Pt 2):497-504
12624211
Nat Methods. 2012 Mar 04;9(4):357-9
22388286
Clin Vaccine Immunol. 2010 Nov;17(11):1820-2
20876824
J Clin Microbiol. 2011 May;49(5):1758-64
21411593
J Vis Exp. 2014 Sep 25;(91):51747
25285991
Vaccine. 2010 Mar 11;28(12):2450-7
20067753
BMC Bioinformatics. 2010 Dec 10;11:595
21143983
J Microbiol Methods. 2015 Jun;113:41-9
25819558
Nat Genet. 2014 Mar;46(3):305-9
24509479
Infect Immun. 2003 Nov;71(11):6192-8
14573636
BMC Infect Dis. 2010 Sep 24;10:282
20868480
J Biochem. 1998 May;123(5):937-45
9562629
Mt Sinai J Med. 1976 Nov-Dec;43(6):699-709
13297
Genome Res. 2010 Sep;20(9):1297-303
20644199
Mol Biol Evol. 2013 Dec;30(12):2725-9
24132122
Bioinformatics. 2014 Aug 1;30(15):2114-20
24695404
MBio. 2012 Apr 24;3(3):null
22532557
Bioinformatics. 2009 Aug 15;25(16):2078-9
19505943
J Clin Microbiol. 2013 Dec;51(12):4193-5
24025905
PLoS One. 2014 May 20;9(5):e98103
24844597
J Infect Dis. 2010 Jul 1;202(1):29-38
20507232
Clin Vaccine Immunol. 2015 Mar;22(3):313-8
25589550
J Biol Chem. 2013 Sep 6;288(36):25976-85
23897812
Bioinformatics. 2014 May 1;30(9):1312-3
24451623
J Bacteriol. 2007 Nov;189(21):7841-55
17766424
PLoS One. 2012;7(9):e44250
22970189
MMWR Morb Mortal Wkly Rep. 2010 Mar 12;59(9):258-61
20224542
J Clin Microbiol. 2003 Jun;41(6):2378-84
12791852
Clin Microbiol Infect. 2016 Jan;22(1):60.e9-60.e29
26363404
J Vis Exp. 2014 Feb 24;(84):e51208
24637727
J Biol Chem. 2012 Aug 10;287(33):27885-94
22736767
J Bacteriol. 2007 Nov;189(21):7856-76
17766420
J Clin Microbiol. 2015 Jul;53(7):2271-85
25972423
PLoS Genet. 2006 Mar;2(3):e31
16532061
Lancet Infect Dis. 2011 Oct;11(10):760-8
21621466
J Biol Chem. 2013 Jul 26;288(30):21945-54
23737526
J Med Microbiol. 1973 May;6(2):187-90
4145340
Bioinformatics. 2009 Jul 15;25(14):1754-60
19451168
J Clin Microbiol. 2014 Jun;52(6):2096-9
24719436
BMC Bioinformatics. 2009 Dec 15;10:421
20003500
J Clin Microbiol. 2016 Apr;54(4):967-71
26818670
Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
7984417
Science. 2011 Jan 28;331(6016):430-4
21273480
J Comput Biol. 2012 May;19(5):455-77
22506599
BMC Microbiol. 2014 Mar 10;14:60
24612771
Vaccine. 2015 Feb 25;33(9):1135-42
25613717
J Clin Microbiol. 2007 Apr;45(4):1225-33
17267625
J Infect Dis. 1983 Jun;147(6):1041-54
6854063